Abstract:Inhaled medication is the cornerstone in the treatment of patients across a spectrum of respiratory diseases including asthma and chronic obstructive pulmonary disease. The benefits of inhaled therapy have long been recognised but the most important innovations have occurred over the past 60 years, beginning with the invention of the pressurised metered dose inhaler. However, despite over 230 different device and drug combinations currently being available, disease control is far from perfect. Here we look at how innovation in inhaler design may improve treatments for respiratory diseases and how new formulations may lead to treatments for diseases beyond the lungs. We look at the three main areas where innovation in inhaled therapy is most likely to occur: 1) device engineering and design; 2) chemistry and formulations; and 3) digital technology associated with inhalers. Inhaler design has improved significantly but considerable challenges still remain in order to continually innovate and improve targeted drug delivery to the lungs. Healthcare professionals want see innovations that motivate their patients to achieve their goal of improving their health, through better adherence to treatment. Patients want devices that are easy to use and to see that their efforts are rewarded by improvements in their condition. Key points The dictionary definition of innovation is the introduction of new things, ideas or ways of doing something. We show how this definition can be applied to inhaled therapy. We take a look at the past to see what drove innovation in inhaler design and how this has led to the current devices. We look at the current drivers of innovation in engineering, chemistry and digital technology and predict how this may translate to new devices. Can innovation help the healthcare professional manage their patients better? What does the patient expect from innovation in their device? Educational aims To understand the importance of inhaled medication in the treatment of lung diseases. To understand how innovation has helped advance some of the devices patients use today from basic and inefficient designs. To understand the obstacles that prevent patients from receiving optimal treatment from their inhalers. To understand how innovation in inhaler design can lead to improved treatment for patients and widen the range of diseases that can be treated via the inhaled route.

Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma

Advances in the Discovery of Novel Inhaled PI3K Inhibitors for the Treatment of Asthma

New Advances and Potential Therapies for the Treatment of Asthma

Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models

New developments in asthma therapeutics

Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma

Currently Available Inhaled Therapies in Asthma and Advances in Drug Delivery and Devices

New therapies and management strategies in the treatment of asthma: patient-focused developments

Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management

Is there room for further innovation in inhaled therapy for airways disease?

Future treatment for asthma

Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases

Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders

Digital Inhalers and Remote Patient Monitoring for Asthma

Investigational approaches for unmet need in severe asthma

Inhaled Medicines: Past, Present, and Future

New insights into asthma pathogenesis and treatment

Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there room for improvement?

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers

Application of nano- and micro-particle-based approaches for selected bronchodilators in management of asthma